HomeInsightsResults

Rpg Life Sciences Ltd Quarterly Result

Rpg Life Sciences Ltd Quarterly Result

stocks purchased

₹ 1.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

7.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

RPG Life Sciences Ltd

NSE: RPGLIFE

Net Profit

₹ 4.2

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of RPG Life Sciences Ltd for the Sep '24 is ₹ 174.15 crore as compare to the Jun '24 revenue of ₹ 167.79 crore. This represent the growth of 3.790453%.
  • The ebitda of RPG Life Sciences Ltd for the Sep '24 is ₹ 20.57 crore as compare to the Jun '24 ebitda of ₹ 41.44 crore. This represent the decline of -50.36197%.
  • The net profit of RPG Life Sciences Ltd for the Sep '24 is ₹ 4.2 crore as compare to the Jun '24 net profit of ₹ 26.76 crore. This represent the decline of -84.30494%.

Results Analysis

Market Price of RPG Life Sciences Ltd

1M

1Y

3Y

5Y

Monitoring RPG Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241986.05
21 Nov 20242035.15
19 Nov 20242043.35
18 Nov 20242090.65
14 Nov 20242149.05
13 Nov 20242162.45
12 Nov 20242256.2
11 Nov 20242350.85
08 Nov 20242486.5
07 Nov 20242650

Historical Revenue of RPG Life Sciences Ltd

No data available

* All values are in crore

Historical EBITDA of RPG Life Sciences Ltd

No data available

* All values are in crore

Historical Net Profit of RPG Life Sciences Ltd

No data available

* All values are in crore

RPG Life Sciences Ltd News Hub

News

RPG Life Sciences announces board meeting date

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 7 Novemb...

Read more

02 Nov 202413:45

News

RPG Life Sciences to announce Quarterly Result

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 19 July ...

Read more

13 Jul 202410:33

News

RPG Life Sciences to convene AGM

RPG Life Sciences announced that the Annual General Meeting (AGM) of the company will be h...

Read more

12 Jun 202413:44

News

Board of RPG Life Sciences recommends final dividend

RPG Life Sciences announced that the Board of Directors of the Company at its meeting held...

Read more

02 May 202411:08

News

RPG Life Sciences to hold board meeting

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 30 April...

Read more

24 Apr 202410:29

News

RPG Life edges higher after ICRA upgrades LT rating to 'A+'

The credit rating agency has reaffirmed the company’s short-term rating at ‘ICRA] A1’. ICR...

Read more

06 Mar 202412:54

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Rpg Life Sciences Ltd Quarterly Result

What is the EPS of RPG Life Sciences Ltd stock?

The Earnings Per Share (EPS) of RPG Life Sciences Ltd is 52.65. An EPS is the amount of net income attributed to each share of a common stock.

How is RPG Life Sciences Ltd EPS calculated?

The EPS of RPG Life Sciences Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does RPG Life Sciences Ltd report its EPS?

RPG Life Sciences Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence RPG Life Sciences Ltd EPS?

Factors that influence the EPS of RPG Life Sciences Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can RPG Life Sciences Ltd EPS growth indicate future performance?

Yes, consistent growth in RPG Life Sciences Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*